News

Apply Now for the Shauna M. Sorrells Program

In 2020, G2G Consulting launched the Shauna M. Sorrells Program to provide a $10,000 grant to a nonprofit that dedicates meaningful services and programs to women and children, especially women of color.

Award winners have provided programming in breast cancer screening services, maternal health, housing, STEM education programs, adult literacy, domestic violence shelter, and career advancement services.

⮕ How it Works:

Grants are for small nonprofits providing services to women and children and communities of color. All applicants must be a nonprofit with an annual budget of $3 million or less. Preference is granted to organizations serving women and children, especially people of color. If you have been awarded grants twice before, you are not eligible for funding. Once three finalists are selected, the voting begins to select the Grand Prize Winner.

Applications are open October 1 – 27.

 

Apply Now

Recent News

04/15/2026

Gov. Spanberger and Homegrown Innovator Agrospheres Celebrate Launch of Virginia’s new Biomanufacturing Facility

AgroSpheres, Inc., a Charlottesville-based agricultural biotechnology company, officially opened its first commercial biomanufacturing facility, representing a milestone for AgroSpheres and the biotech ecosystem. Speakers at the ribbon-cutting ceremony included: Virginia Governor Abigail Spanberger, AgroSpheres co-founders CEO Payam Pourtaheri and CTO Ameer Shakeel, Albemarle County Chair of the Board of Supervisors Ned Gallaway, President of the

04/08/2026

Likarda and The Tiny Cargo Company Announce Strategic Partnership to Advance Next-Generation Delivery of Biologics, Peptides and Small Molecules

Likarda, Inc., a leader in hydrogel-based drug delivery technologies, today announced a strategic partnership with Tiny Cargo, an innovator in extracellular vesicle (EV) delivery systems. The collaboration will focus on advancing the delivery of biologics and small molecules by integrating Likarda’s Core-Shell Spherification® (CSS®) platform with Tiny Cargo’s vesicle-based technologies. The partnership is designed to

04/08/2026

ReAlta Life Sciences Closes Oversubscribed $40 Million Financing Round to Advance Pegtarazimod Phase 2 Program in Hypoxic Ischemic Encephalopathy (HIE)

ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to potentially revolutionize the treatment of inflammatory disorders, today announced the closing of an oversubscribed $40 million financing. This brings the total capital raised to date to more than $150 million.